Axitinib-13C,d3 (CAS 1261432-00-1) is a high-purity isotopically labeled compound used in advanced pharmaceutical research. This version of Axitinib, labeled with carbon-13 and three deuterium atoms, is essential for studies involving tyrosine kinase inhibitors, cancer therapeutics, pharmacokinetics, and metabolic pathways. The precise isotopic labeling ensures accurate and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for oncology research and drug development, Axitinib-13C,d3 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.
| Catalog Number | S000059 |
| CAS Number | 1261432-00-1 |
| Molecular Formula | C2113CH15D3N4OS |
| Purity | 95% |
| IUPAC Name | 2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]-N-(trideuterio(113C)methyl)benzamide |
| InChI | InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+/i1+1D3 |
| InChIKey | RITAVMQDGBJQJZ-QUYHSVBSSA-N |
| SMILES | [2H][13C]([2H])([2H])NC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4 |
